Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Huber

Showing results (311-320 of 752) with videos related to

Pageof 76
Sort By:
Atherosclerosis|June 3, 2008
Implantation of paclitaxel-eluting stent impairs the vascular compliance of arteries in porcine coronary stenting modelSerdar Farhan, Rayyan Hemetsberger, Johannes Matiasek, et al.
Journal of Cellular and Molecular Medicine|September 15, 2018
Cardioprotective cytokine interleukin-33 is up-regulated by statins in human cardiac tissueRichard Pentz, Christoph Kaun, Barbara Thaler, et al.
Thrombosis and Haemostasis|November 4, 2011
Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on ThrombosisGregory Y H Lip, Felicita Andreotti, Laurent Fauchier, et al.
Thrombosis and Haemostasis|December 24, 2003
A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with increased bilirubin and HDL levels but not with coronary artery diseaseGeorg Endler, Markus Exner, Martin Schillinger, et al.
Circulation|April 13, 2005
Simvastatin blunts endotoxin-induced tissue factor in vivoSabine Steiner, Walter S Speidl, Johannes Pleiner, et al.
Thrombosis Research|July 13, 2023
Blood group non-O is not associated with long-term adverse outcomes in patients undergoing percutaneous coronary interventionMaximilian Tscharre, Serdar Farhan, Matthias K Freynhofer, et al.
Circulation. Cardiovascular Interventions|December 13, 2012
A validated risk score to predict outcomes after carotid stentingMatthias Hoke, Elmir Ljubuncic, Clemens Steinwender, et al.
European Journal of Clinical Investigation|February 17, 2016
Soluble galectin-3 is associated with premature myocardial infarctionMax-Paul Winter, Franz Wiesbauer, Arman Alimohammadi, et al.
Wiener Klinische Wochenschrift|August 20, 2021
Long-term outcome in patients with takotsubo syndrome : A single center study from ViennaEdita Pogran, Ahmed Abd El-Razek, Laura Gargiulo, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 15, 2019
Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysisPaul M Haller, Patrick Sulzgruber, Christoph Kaufmann, et al.
Pageof 76

Showing results (311-320 of 752) with videos related to

Sort By:
Pageof 76
Atherosclerosis|June 3, 2008
Implantation of paclitaxel-eluting stent impairs the vascular compliance of arteries in porcine coronary stenting modelSerdar Farhan, Rayyan Hemetsberger, Johannes Matiasek, et al.
Journal of Cellular and Molecular Medicine|September 15, 2018
Cardioprotective cytokine interleukin-33 is up-regulated by statins in human cardiac tissueRichard Pentz, Christoph Kaun, Barbara Thaler, et al.
Thrombosis and Haemostasis|November 4, 2011
Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on ThrombosisGregory Y H Lip, Felicita Andreotti, Laurent Fauchier, et al.
Thrombosis and Haemostasis|December 24, 2003
A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with increased bilirubin and HDL levels but not with coronary artery diseaseGeorg Endler, Markus Exner, Martin Schillinger, et al.
Circulation|April 13, 2005
Simvastatin blunts endotoxin-induced tissue factor in vivoSabine Steiner, Walter S Speidl, Johannes Pleiner, et al.
Thrombosis Research|July 13, 2023
Blood group non-O is not associated with long-term adverse outcomes in patients undergoing percutaneous coronary interventionMaximilian Tscharre, Serdar Farhan, Matthias K Freynhofer, et al.
Circulation. Cardiovascular Interventions|December 13, 2012
A validated risk score to predict outcomes after carotid stentingMatthias Hoke, Elmir Ljubuncic, Clemens Steinwender, et al.
European Journal of Clinical Investigation|February 17, 2016
Soluble galectin-3 is associated with premature myocardial infarctionMax-Paul Winter, Franz Wiesbauer, Arman Alimohammadi, et al.
Wiener Klinische Wochenschrift|August 20, 2021
Long-term outcome in patients with takotsubo syndrome : A single center study from ViennaEdita Pogran, Ahmed Abd El-Razek, Laura Gargiulo, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 15, 2019
Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysisPaul M Haller, Patrick Sulzgruber, Christoph Kaufmann, et al.
Pageof 76